Grufity logoGrufity logo

HYPR

0.79USD+0.02(+2.60%)Delayedas of 28 Nov 2022, 01:44 pm

Hyperfine, Inc.

Market Summary

USD0.79+0.02Delayedas of 28 Nov 2022, 01:44 pm
2.60%

HYPR Alerts

HYPR Stock Price

RSI Chart

Valuation

Market Cap

67.6M

Price/Earnings

-0.91

Price/Sales

11.1

Price/Cashflow

-0.75

MarketCap/EBT

-0.61

Price/Sales

Profitability

EBT Margin

-1811.35%

Return on Equity

-49.11%

Return on Assets

-45.71%

Fundamentals

Revenue

Revenue (TTM)

5.8M

Revenue Y/Y

532.88%

Revenue Q/Q

53.16%

Earnings

Earnings (TTM)

-86.2M

Earnings Y/Y

-1.4K%

Earnings Q/Q

43.13%

Price Action

52 Week Range

0.7216.61
(Low)(High)

Last 7 days

-3.7%

Last 30 days

-22.1%

Last 90 days

-41.2%

Trailing 12 Months

-92.3%

Financial Health

Current Ratio

15.02

Investor Care

Shares Dilution (1Y)

4144.75%

Diluted EPS (TTM)

-11.02

Financials for Hyperfine

Income Statement (Last 12 Months)
(In Thousands)
Description(%) Q/Q2022Q32022Q22022Q12021Q42021Q3
Revenue51.4%5,8263,8492,6741,4961,413
Gross Profit117.7%154-872.00-806.00-1,167.00-910.00
Operating Expenses17.8%86,48673,41664,87663,70130,554
  S&GA Expenses4.2%15,93715,29013,32710,3626,743
  R&D Expenses2.9%31,83030,93029,70225,84220,500
Earnings Before Taxes3.6%-86,190.00-89,411.00-67,685.89-64,851.00-24,836.66
Net Income-16.6%-86,190.00-73,916.75-52,191.65-64,851.00-3,307.22
Balance Sheet
(In Millions)
Description(%) Q/Q2022Q32022Q22022Q12021Q42021Q3
Assets-8.3%14816217920281
  Current Assets-8.5%14415717419776
    Cash Equivalents-8.7%1321451621881
  Inventory-13.9%45543
  Net PPE-1.4%33443
Liabilities19.2%131112169
  Current Liabilities19.2%121011162
Shareholder's Equity-10.3%135151167186-101.06
  Retained Earnings-7.2%-196.42-183.25-160.09-136.32-110.23
  Additional Paid-In Capital-0.7%3313343273239
Accumulated Depreciation13.0%2221-
Shares Outstanding0.0%707045-
* denotes actual numbers (not divided by Millions)
Cashflow (Last 12 Months)
(In Thousands)
Description(%) Q/Q2022Q32022Q22022Q12021Q42021Q3
Cashflow From Operations17.1%-75,129.00-90,646.30-73,825.40-47,182.00-38,729.33
  Share Based Compensation-31.4%7,36910,7456,9013,391
Cashflow From Investing-0.1%203,862204,035-2,849.00-2,711.00-207,773.00
Cashflow From Financing-0.9%282,656285,184176,76747,252

Risks

What is the probability of a big loss on HYPR?

50%


Probability that Hyperfine stock will be more than 20% underwater in next one year

50%


Probability that Hyperfine stock will be more than 30% underwater in next one year.

47.9%


Probability that Hyperfine stock will be more than 40% underwater in next one year.
*Calculated based on probability distribution of losses observed in actual data in the last 5 years.

How does HYPR drawdown profile look like?

Y-axis is the maximum loss one would have experienced if Hyperfine was unfortunately bought at previous high price.

Returns

Cumulative Returns on HYPR

Which funds bought or sold HYPR recently?

View All Details
Datesorted ascendingFund NameType% Chg$ Change$ Held% Portfolio
2022-11-15
CONCOURSE FINANCIAL GROUP SECURITIES, INC.
SOLD OFF
-
-
-
-%
2022-11-15
STATE STREET CORP
ADDED
5.3
-198,000
122,000
-%
2022-11-15
MERCER GLOBAL ADVISORS INC /ADV
ADDED
2.49
-23,000
14,000
-%
2022-11-15
JANE STREET GROUP, LLC
SOLD OFF
-100
-161,000
-
-%
2022-11-15
Alphabet Inc.
UNCHANGED
-
-1,276,000
728,000
0.04%
2022-11-14
CITADEL ADVISORS LLC
NEW
-
57,000
57,000
-%
2022-11-14
SUSQUEHANNA INTERNATIONAL GROUP, LLP
NEW
-
15,000
15,000
-%
2022-11-14
Fosun International Ltd
-
-
-2,474,000
1,411,000
0.15%
2022-11-14
Alyeska Investment Group, L.P.
-
-
-1,065,000
608,000
0.01%
2022-11-14
HRT FINANCIAL LP
-
-
-85,000
18,000
-%

1–10 of 45

Latest Funds Activity

Are funds buying HYPR calls or puts?
Are funds bullish or bearish(Calls - Puts)?
No. of funds that own HYPR

Hyperfine News

Marketscreener.com

Hyperfine to Present at the 5th Annual Evercore ISI HealthCONx Conference.5 days ago

GlobeNewswire

HYPR Fair Value

Recent SEC filings of Hyperfine

View All Filings
Date Filed Form Type Document
Nov 23, 2022
424B3
Prospectus Filed
Nov 23, 2022
8-K
Current Report
Nov 16, 2022
4
Insider Trading
Nov 16, 2022
4
Insider Trading
Nov 16, 2022
4
Insider Trading
Nov 15, 2022
8-K/A
Current Report
Nov 15, 2022
424B3
Prospectus Filed
Nov 15, 2022
4
Insider Trading
Nov 14, 2022
4
Insider Trading
Nov 14, 2022
424B3
Prospectus Filed

Latest Insider Trading transactions for HYPR

Filter Transactions
Datesorted ascendingNameBuy/Sell$ ValueAvg. Price# SharesTitle
2022-11-16
Paykel Neela
SOLD
-1,591.8
0.84
-1,895
Gen Counsel & Corp Secretary
2022-11-16
Gupta Alok
SOLD
-1,870.68
0.84
-2,227
Chief Financial Officer
2022-11-16
Siddiqui Khan
SOLD
-87,276
84
-1,039
CMO and Chief Strategy Officer
2022-11-15
ROTHBERG JONATHAN M
BOUGHT
28,647.9
0.92
31,139
-
2022-11-14
ROTHBERG JONATHAN M
BOUGHT
30,694.3
0.89
34,488
-
2022-08-16
ROTHBERG JONATHAN M
BOUGHT
95,163.7
1.482
64,213
-
2022-08-15
Paykel Neela
SOLD
-2,741.95
1.45
-1,891
Gen Counsel & Corp Secretary
2022-08-15
Siddiqui Khan
SOLD
-1,500.75
1.45
-1,035
CMO and Chief Strategy Officer
2022-08-15
Gupta Alok
SOLD
-12,863
1.45
-8,871
Chief Financial Officer
2022-08-12
ROTHBERG JONATHAN M
BOUGHT
441,671
1.457
303,137
-

1–10 of 41

David D. Scott
190
Hyperfine, Inc. provides imaging, monitoring, and magnetic resonance imaging products. It offers Swoop Portable MR imaging system to address an unmet need in point-of-care medical imaging through a combination of hardware and software services. The company was incorporated in 2014 and is based in Guilford, Connecticut.

HYPR Income Statement

2022-09-30
CONDENSED COMBINED AND CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS (Unaudited) - USD ($)
$ in Thousands
3 Months Ended9 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Sep. 30, 2022
Sep. 30, 2021
Sales    
Total sales$ 2,348$ 371$ 5,390$ 1,060
Cost of sales    
Total cost of sales1,6607094,7831,774
Gross margin688(338)607(714)
Operating Expenses:    
Research and development7,3386,43822,93716,949
General and administrative3,1986,82726,57015,348
Sales and marketing3,4342,78711,3455,770
Total operating expenses13,97016,05260,85238,067
Loss from operations(13,282)(16,390)(60,245)(38,781)
Interest income170320313
Other income (expense), net(59)(5)(63)2
Loss before provision for income taxes(13,171)(16,392)(60,105)(38,766)
Provision for income taxes0000
Net loss and comprehensive loss$ (13,171)$ (16,392)$ (60,105)$ (38,766)
Earnings Per Share, Basic$ (0.19)$ (8.66)$ (0.85)$ (22.56)
Earnings Per Share, Diluted$ (0.19)$ (8.66)$ (0.85)$ (22.56)
Denominator for Basic EPS - Weighted-average common stock70,509,6391,892,20870,398,1031,718,489
Denominator for Dilutive EPS - Weighted-average common stock70,509,6391,892,20870,398,1031,718,489
Device    
Sales    
Total sales$ 1,945$ 200$ 4,305$ 521
Cost of sales    
Total cost of sales1,2155083,5111,420
Service    
Sales    
Total sales4031711,085539
Cost of sales    
Total cost of sales$ 445$ 201$ 1,272$ 354

HYPR Balance Sheet

2022-09-30
CONDENSED COMBINED AND CONSOLIDATED BALANCE SHEETS (Unaudited) - USD ($)
$ in Thousands
Sep. 30, 2022
Dec. 31, 2021
CURRENT ASSETS:  
Cash and cash equivalents$ 132,482$ 188,498
Restricted cash1,2592,662
Accounts receivable, less allowance of $151 and $32 as of June 30, 2022 and December 31, 2021, respectively2,702553
Unbilled receivables1,47591
Inventory4,0024,310
Prepaid expenses and other current assets1,7961,357
Due from related parties 14
Total current assets143,716197,485
Property and equipment, net3,4483,753
Other long term assets1,1671,235
Total assets148,331202,473
CURRENT LIABILITIES:  
Accounts payable7412,248
Deferred grant funding1,2592,662
Deferred revenue1,449730
Due to related parties611,981
Accrued expenses and other current liabilities8,9498,115
Total current liabilities12,45915,736
Long term deferred revenue889510
Total liabilities13,34816,246
COMMITMENTS AND CONTINGENCIES (NOTE 12)
STOCKHOLDERS' EQUITY:  
Additional paid-in capital331,401322,540
Accumulated deficit(196,425)(136,320)
Total stockholders' equity134,983186,227
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY148,331202,473
Class A Common Stock  
STOCKHOLDERS' EQUITY:  
Common stock55
Class B Common Stock  
STOCKHOLDERS' EQUITY:  
Common stock$ 2$ 2